Genetic Testing Can Help Prevent Serious Reactions To Seizure Medicines
This paper describes a prescribing guideline, not a new clinical trial.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
This paper describes a prescribing guideline, not a new clinical trial.
Researchers compiled clinical and genetic information from 95 people with DNM1-related disorder, a rare developmental and epileptic encephalopathy.
This abstract describes a planned early-stage clinical trial, not study results.
This paper was a systematic review about precision medicine for epilepsy linked to changes in potassium channel genes.
This study looked at diffusion-weighted MRI abnormalities seen around the time of status epilepticus in adults.
This study combined results from earlier studies about what people in Arabic-speaking countries in the Eastern Mediterranean Region know and believe about epilepsy.
This study looked at GNAO1-related disorders, a group of rare genetic conditions that can cause epilepsy, movement problems, and developmental impairment.
This study looked at 30 newborns with epilepsy associated with changes in the KCNQ2 gene.
This study combined results from 73 observational studies that reported how often people with epilepsy also had headaches.